After decades of relying on treatments approved for other diseases, on January 15, 2021 the FDA approved the first drug for AL Amyloidosis. Truly a game-changing, monumental advancement in the treatment of this disease.
WOW, what a year! A year no one saw coming, yet we are proud to say we advanced our mission in many impactful ways, thanks to YOU, our wonderful supporters! Please enjoy reading our 2020 Report Card on how your support helped fuel our work to educate future physicians and support game-changing medical research.